Articles On dorsaVi (ASX:DVL)

“Your Stock Request” is a weekly video where we analyse share price charts for stocks on the Australian market (ASX) as requested by you! Email us at [email protected] with your stock request. Limit of one per person, no guarantee o...

dorsaVi (ASX: DVL) has embarked on a formal evaluation program to upscale its oxide-based resistive random access memory from 40 nanometers to an advanced 22nm process node.

Optiscan Imaging led the biotech pack in October, while some of the Big Four stocks were late scratchings Does CSL have an iron deficiency? Weebit Nano ‘mini me’ Dorsavi quietly jockeys for position in the high-stakes chip race   The ASX...

Echo IQ has had a “frustrating” US reimbursement rejection, but there’s a Plan B Artrya signs up US hospital heart heavy hitter for its Sapphire trial Dorsavi gains traction in the US physical therapy sector   Heart disease detection play...

dorsaVi (ASX: DVL) has achieved a technical breakthrough in the evaluation of its robotic RRAM reflex platform, demonstrating that memory is no longer the bottleneck in achieving biological-grade reflexes. The platform has shown itself capa...

Emvision secures $12 million in a placement, with up to $3 million to come in a share purchase plan Painchek’s Highland Fling reaps trial rewards Visionflex cleans up its balance sheet   Emvision Medical Devices (ASX:EMV) has replenished...

dorsaVi (ASX: DVL) has launched Artemis Labs, a wholly owned subsidiary focused on advancing robotics, artificial intelligence and sensor technologies. The new division will merge dorsaVi’s FDA-cleared movement analytics with resistive rand...

Apiam Health shares surge 50% on $124 million private equity takeover approach Audeara’s update is news to investor ears Dorsavi’s robotic moves result in $5 million raising   Apiam Animal Health (ASX:AHX) has received a $124 million non...

An internal assessment of dorsaVi’s (ASX: DVL) resistive random access memory (RRAM) technology has confirmed its suitability for high-speed, low-power usage in embedded, wearable and AI-driven devices. Head-to-head comparisons with industr...

Motion analysis device developer dorsaVi (ASX: DVL) has delivered its resistive random-access memory (RRAM)-powered sensor systems to Singapore for comprehensive testing in real-world biomedical contexts. Testing will focus on edge-device f...

dorsaVi (ASX: DVL) has secured an exclusive worldwide licence to a cutting-edge resistive random-access memory (RRAM) technology developed by Nanyang Technological University in Singapore. The proposed licence gives the company access to ni...

Morning, and welcome to Stockhead’s Top 10 (at 11… ish), highlighting the movers and shakers on the ASX in early-doors trading. With the market opening at 10am sharp eastern time, the data is taken at 10.30am, once trading kicks off in earn...

Motion analysis device developer dorsaVi (ASX: DVL) has landed a new three-year deal worth $30,000 per annum with leading mining health group SANO Health. The two companies have collaborated for five years on injury prevention and the new a...

ASX dips after US futures drop and Israel strikes Gold hits new high, coal stock New Hope soars BYD’s five-minute battery charge sparks buzz   The ASX made solid gains before pulling back in the afternoon after US stock futures went into...

dorsaVi (ASX: DVL) has launched a first-in-class 3D motion analysis test for the early identification and prevention of anterior cruciate ligament (ACL) injuries in athletes. The commercially available knee assessment tool employs advanced...

ASX rises as banks lead, energy lags Bitcoin hits $107k… $150k target murmurings grow louder  Orica CEO to retire, Data#3 tumbles on Microsoft news   The ASX edged higher by 0.78% on Tuesday, with the big banks keeping the mood upbeat thr...

ASX dips as energy stocks lead losses Global tensions weigh on markets, gold stocks rise China holds rates steady, Nvidia’s earnings later tonight   The ASX slipped from Tuesday’s high, closing lower by 0.57% on Wednesday.  Global worries...

dorsaVi (ASX: DVL) has commenced a feasibility study to incorporate blockchain technology and enhance the security of data on its core motion analysis platform. The study aims to determine how an encrypted, immutable and tamper-proof soluti...

In the words of Sprott analysts: “The world is in the midst of a fourth industrial revolution” with the fast-paced evolution of artificial intelligence (AI), robotics, Internet of Things, genetic engineering and quantum computing. While...

Optiscan to showcase its innovative cloud-based telepathology platform dorsaVi seals crucial contracts across different sectors    Optiscan completes beta testing of breakthrough technology Optiscan Imaging (ASX:OIL), in partnership with...

ASX 200 ends 0.5pc lower after a difficult start to the week Energy Sector the worst of some poor to middling performances Small caps led by AuMake on news of a new deal in China   Last week’s record highs seem a distant memory for the...

dorsaVi CEO Dr Andrew Ronchi said, “I am delighted to announce the release of our Natural Movement Algorithm which will drive new commercial applications within the aged care sector domestically and internationally."

Local markets recover early losses to close slightly ahead Material and Financial gains offset IT and Property losses Small Caps led by ADX Energy   Aussie share markets have recovered from early losses to close Monday, ever so slightly i...

18 Mar 2024 - A snapshot of the stocks on the move, featuring dorsaVi (ASX:DVL), Celsius Resources (ASX:CLA) and Metarock Group (ASX:MYE).

Human movement analytics company dorsaVi (ASX: DVL) has integrated real-time facial tracking into its suite of artificial intelligence (AI)-powered video tracking capabilities available on its touchless movement tracking platform ViMove. Th...

  dorsaVi (ASX:DVL) has successfully integrated real-time facial tracking into its suite of AI-powered video tracking capabilities available in the ViMove+ platform. The advancement builds upon the successful development of lower limb track...

Stockhead’s Top 10 at 10, published at ~10.40am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

  Local markets give up early gains then regains them, closing 0.22pc higher Consumer Discretionary stocks offset losses in materials and Energy  Small Caps led by LBT Innovations   It’s hard to stay afloat when BHP sinks to a near nine-m...

Benchmark ASX index ends +0.21%, but down -2.2% this week Consumer stocks offset Tech losses Small caps led by Webcentral    The benchmark has ended another tortuous week of trade with a little Friday victory. Down -2.2% for the week, all...

ASX weathers a US bank collapse storm to finish the day down just 0.5% XEC Emerging Companies index down 0.84% because it was out partying all weekend. The Goldies take the gongs, after the precious metal jumped more than 1.0%   Looking a...

ASX 200 is up 0.2% and the XEC is down -0.2% Tension stateside ahead of FOMC decision, EU markets to start flat CPI at 6.1% is better than feared but enough to move the RBA next Tuesday And a crack team of small caps broke out of the ordin...

dorsaVi (DVL) extends a deal with insurance provider QBE Australia for another three years The companies signed the original agreement in 2020 which saw dorsaVi provide QBE customers with wearable devices to help reduce injury claims and i...

The ongoing lawsuit involving Johnson & Johnson (J&J)’s talc products took a controversial turn in the courts this week. The healthcare giant is currently staring down 38,000 claims that its talc products (including the famous baby...

Motion analysis device maker dorsaVi (ASX:DVL) has been awarded the internationally recognised ISO 27001 certification, verifying the data security standards for the company . The ISO 27001 standard specifies advanced information security a...

Leading the health stocks today is Genetic Technologies (ASX:GTG) which rose 14.28% after announcing a material increase in cash receipts for the September quarter to $850,000 from $68,000 in the June quarter. The company says the increase...

The ASX had another positive day but, unlike yesterday, held momentum to close at an all time high. The ASX 200 closed at 7,511 points which was an 0.11% gain although the ASX Emerging Companies Index fell 0.63% to 2,226 points. The top sec...

dorsaVi will continue to leverage its technology in the data capture and analysis workstreams, leading to an optimised, customisable product, in line with Medtronic’s objectives.

Summary Decmil (ASX:DCG) receives A$21 million civil balance of plant works contract dorsaVi (ASX:DVL) extends agreement with Medtronic Suvo (ASX:SUV) signs MOU and collaboration agreement with China-based Rezel The S&P/ASX2...

ASX 200 health stocks index (XHJ) rose by 0.23% this morning, compared to the broader index which rose by 0.11%. Micro cap medical device company dorsaVi (ASX:DVL) took the limelight this morning, jumping by 12% after saying that it has ext...

Wearable sensor technology company Dorsavi Ltd‘s (ASX: DVL) share price is up 22% in late afternoon trading after posting gains of more than 32% earlier in the afternoon. This follows on the company’s annual general meeting (AGM) results,...

Here’s our fortnightly wrap of all the news driving ASX health stocks. It was a fortnight of a bit of ... Read More The post Check up: dorsaVi leads ASX health gainers with 60pc rise appeared first on Stockhead.

The coronavirus pandemic has led to a gloomy atmosphere around the world with the infectious disease severely affecting human health and the world economy. In such difficult times, market participants seek positive news to lift their sentim...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Themes of the week Victoria h...

The Dorsavi Ltd (ASX: DVL) share price shot 276.92% higher on Thursday following the announcement of a strategic partnership with QBE Insurance Group Ltd (ASX: QBE). About Dorsavi Dorsavi is a biotechnology company that develops innovative...

Wearable technology can often feel like a fad. dorsaVi Ltd [ASX:DVL] has certainly lent credence to this line of thinking today. The share price in this tech small-cap are trading 515% higher at time of writing. The post dorsaVi Share Pric...

A quick wrap of the key winners and losers on Thursday, July 2. Data is taken after the market closes at 4pm EST. Stocks highlighted in yellow made market-moving announcements during the day. Today 896 stocks rose, 428 declined and 785 were...

Wearable sensor technology developer dorsaVi (ASX: DVL) and Australia’s second-largest global insurer QBE Insurance (ASX: QBE) have agreed to a one-year “commercial collaboration”, that will see QBE’s customers gaining access to dorsaVi’s w...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

A quick wrap of the key winners and losers on Wednesday, May 27. Data is taken after the market closes at 4pm EST. Stocks highlighted in yellow made market-moving announcements during the day. Code Company Price % Change Volum...

A quick wrap of the key winners and losers on Tuesday, May 12. Data is taken after the market closes at 4pm EST. Stocks highlighted in yellow made market-moving announcements during the day. Code Company Price % Change Volume...